Provided by Tiger Trade Technology Pte. Ltd.

Cencora Inc.

320.95
-2.3700-0.73%
Post-market: 320.950.00000.00%17:36 EDT
Volume:1.35M
Turnover:434.04M
Market Cap:61.25B
PE:23.84
High:327.90
Open:326.34
Low:320.91
Close:323.32
52wk High:377.54
52wk Low:244.82
Shares:190.83M
Float Shares:182.66M
Volume Ratio:0.97
T/O Rate:0.74%
Dividend:2.35
Dividend Rate:0.73%
EPS(TTM):13.46
EPS(LYR):7.96
ROE:96.87%
ROA:3.56%
PB:20.07
PE(LYR):40.32

Loading ...

U.S. Research Roundup-Caterpillar, Eli Lilly, McKesson

Reuters
·
Aug 06

Cencora : Leerink Partners Raises Target Price to $380.00 from $368.00

THOMSON REUTERS
·
Aug 06

Cencora Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 06

McKesson Raises Annual Profit Forecast on Strong Growth in Specialty Drug Business

Reuters
·
Aug 06

Cencora Sees Specialty Growth Continue While GLP-1 Mix Weighs on Margins

Benzinga Earnings
·
Aug 06

Movement Alert|Cencora Inc. Rises 3.78% in Regular Trading, Q3 Earnings Beat Expectations with Full-Year Guidance Raised

Market Focus
·
Aug 06

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cencora (COR), American Well (AMWL) and BeOne Medicines (ONC)

TIPRANKS
·
Aug 05

Stock Track | Cencora Soars 5.21% in pre-market as Fiscal Q3 Earnings Beat and Annual Profit Forecast Raised

Stock Track
·
Aug 05

Cencora, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

U.S. Stocks on the MOVE-Cencora, Charles River, Twist Bioscience

Reuters
·
Aug 05

Cencora CFO: Mwi Animal Health–Covetrus Merger Would Have $150M Operating-Income Headwind if the Transaction Closes- Conf Call

THOMSON REUTERS
·
Aug 05

Cencora Exec: Our Focus is on Accretive Tuck-in Acquisitions Within the Retina and Oncology Space- Conf Call

THOMSON REUTERS
·
Aug 05

Cencora - Enters Amended and Restated Credit Agreement on July 31, 2026 - SEC Filing

Reuters
·
Aug 05

Cencora Shares Rise 3% Premarket After Co Lifts Annual Profit Forecast

THOMSON REUTERS
·
Aug 05

Cencora Lifts Annual Profit View on Strong Demand for Specialty Medicines

Reuters
·
Aug 05

Cencora Ups Multi-Currency Revolving Credit Facility to $7 Billion, Extends Maturity to July 2031

Reuters
·
Aug 05

Cencora - Increases Credit Facility to $7 Bln, Extends Maturity to July 2031 - SEC Filing

THOMSON REUTERS
·
Aug 05

Cencora's Q3 Revenue Slightly Beats Estimates on Healthcare Solutions Growth

Reuters
·
Aug 05

GUIDANCE: (COR) Cencora Expects Fiscal 2026 Adjusted EPS Range $17.75 to $17.95, vs. FactSet Est of $17.78

MT Newswires Live
·
Aug 05

Cencora Q3 Adjusted EPS USD 4.48 Vs. IBES Estimate USD 4.35

Reuters
·
Aug 05